In the past week, ORGO stock has gone up by 31.46%, with a monthly gain of 31.87% and a quarterly surge of 67.46%. The volatility ratio for the week is 5.90%, and the volatility levels for the last 30 days are 4.83% for Organogenesis Holdings Inc. The simple moving average for the past 20 days is 35.43% for ORGO’s stock, with a 46.22% simple moving average for the past 200 days.
Is It Worth Investing in Organogenesis Holdings Inc (NASDAQ: ORGO) Right Now?
The 36-month beta value for ORGO is also noteworthy at 1.68. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ORGO is 77.76M, and at present, short sellers hold a 12.59% of that float. The average trading volume of ORGO on November 13, 2024 was 478.59K shares.
ORGO) stock’s latest price update
Organogenesis Holdings Inc (NASDAQ: ORGO)’s stock price has gone rise by 22.32 in comparison to its previous close of 3.45, however, the company has experienced a 31.46% increase in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Organogenesis Holdings, Inc. (NASDAQ:ORGO ) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Gary Gillheeney – President, Chief Executive Officer & Chair Dave Francisco – Chief Financial Officer Conference Call Participants Ross Osborne – Cantor Fitzgerald Ryan Zimmerman – BTIG Operator Please stand by. Welcome ladies and gentlemen to the Third Quarter of Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants are placed in listen-only mode.
Analysts’ Opinion of ORGO
Many brokerage firms have already submitted their reports for ORGO stocks, with Lake Street repeating the rating for ORGO by listing it as a “Buy.” The predicted price for ORGO in the upcoming period, according to Lake Street is $5 based on the research report published on June 28, 2024 of the current year 2024.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see ORGO reach a price target of $5. The rating they have provided for ORGO stocks is “Overweight” according to the report published on February 07th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to ORGO, setting the target price at $5 in the report published on June 15th of the previous year.
ORGO Trading at 42.49% from the 50-Day Moving Average
After a stumble in the market that brought ORGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.31% of loss for the given period.
Volatility was left at 4.83%, however, over the last 30 days, the volatility rate increased by 5.90%, as shares surge +36.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +64.07% upper at present.
During the last 5 trading sessions, ORGO rose by +38.00%, which changed the moving average for the period of 200-days by +26.93% in comparison to the 20-day moving average, which settled at $3.13. In addition, Organogenesis Holdings Inc saw 3.18% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ORGO starting from ERANI ALBERT, who sale 197,921 shares at the price of $4.37 back on Jan 09 ’24. After this action, ERANI ALBERT now owns 59,025,106 shares of Organogenesis Holdings Inc, valued at $863,985 using the latest closing price.
ERANI ALBERT, the 10% Owner of Organogenesis Holdings Inc, sale 17,972 shares at $4.28 during a trade that took place back on Jan 10 ’24, which means that ERANI ALBERT is holding 59,007,134 shares at $76,875 based on the most recent closing price.
Stock Fundamentals for ORGO
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.73 for the gross margin
The net margin for Organogenesis Holdings Inc stands at -0.02. The total capital return value is set at -0.03. Equity return is now at value -6.19, with -3.70 for asset returns.
Based on Organogenesis Holdings Inc (ORGO), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is -9.32.
Currently, EBITDA for the company is 36.03 million with net debt to EBITDA at -5.52. When we switch over and look at the enterprise to sales, we see a ratio of 1.09. The receivables turnover for the company is 4.49for trailing twelve months and the total asset turnover is 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.73.
Conclusion
In summary, Organogenesis Holdings Inc (ORGO) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
